United States

MAP Pharmaceuticals, Inc. (MAPP)

Track

Ticker: MAPP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
HENWOOD GERALDINE Non-Executive Director
Transaction date
Planned sale
Price
59.22
Quantity 27,975 -28.1%
Value US$4,587,950
GIANAKAKOS ANASTASIOS SVP, Chief Business Officer Officer
Transaction date
Planned sale
Price
424.76
Quantity 2,081 -9.4%
Value US$1,785,509
Borland Scott SVP, Neurology Franchise Officer
Transaction date
Sale
Price
297.46
Quantity 4,131 -47.6%
Value US$3,585,821
NELSON TIMOTHY S President and CEO Executive Director
Transaction date
Planned sale
Price
24.76
Quantity 80,000 -70.8%
Value US$1,980,800
ARMER THOMAS A Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
24.76
Quantity 59,620 -31.6%
Value US$1,476,191
GIANAKAKOS ANASTASIOS SVP, Chief Business Officer Officer
Transaction date
Planned sale
Price
24.76
Quantity 30,000 -67.7%
Value US$742,800
HENWOOD GERALDINE Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 3,750 -100.0%
Value US$56,250
HENWOOD GERALDINE Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 1,490 -100.0%
Value US$22,350
GIANAKAKOS ANASTASIOS SVP, Chief Business Officer Officer
Transaction date
Planned sale
Price
15.64
Quantity 5,767 -31.8%
Value US$90,203
GIANAKAKOS ANASTASIOS SVP, Chief Business Officer Officer
Transaction date
Planned sale
Price
14.38
Quantity 2,500 -16.8%
Value US$35,946
GIANAKAKOS ANASTASIOS SVP, Chief Business Officer Officer
Transaction date
Planned sale
Price
17.50
Quantity 10,000 -44.7%
Value US$175,000
Friedman Charlene A SVP, Gen Counsel & Sec Officer
Transaction date
Planned sale
Price
17.50
Quantity 10,000 -88.4%
Value US$175,000
GIANAKAKOS ANASTASIOS SVP & Chief Business Officer Officer
Transaction date
Planned sale
Price
15.99
Quantity 1,385 -10.1%
Value US$22,153
GIANAKAKOS ANASTASIOS SVP & Chief Business Officer Officer
Transaction date
Planned sale
Price
16.02
Quantity 1,115 -8.3%
Value US$17,864
ARMER THOMAS A Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
15.62
Quantity 30,999 -17.2%
Value US$484,142
ARMER THOMAS A Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 19,868 -8.7%
Value US$298,020
GIANAKAKOS ANASTASIOS SVP & Chief Business Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 10,000 -44.7%
Value US$150,000
GIANAKAKOS ANASTASIOS SVP & Chief Business Officer Officer
Transaction date
Planned sale
Price
13.88
Quantity 4,471 -32.4%
Value US$62,078
NELSON TIMOTHY S President and CEO Executive Director
Transaction date
Planned sale
Price
14.52
Quantity 6,638 -17.5%
Value US$96,414
NELSON TIMOTHY S President and CEO Executive Director
Transaction date
Planned sale
Price
14.50
Quantity 13,362 -29.9%
Value US$193,809
GIANAKAKOS ANASTASIOS SVP & Chief Bus Officer Officer
Transaction date
Planned sale
Price
8,672.00
Quantity 13 -0.1%
Value US$113,190
GIANAKAKOS ANASTASIOS SVP & Chief Bus Officer Officer
Transaction date
Planned sale
Price
13.28
Quantity 1,328 -12.5%
Value US$17,630
CHAI CHRISTOPHER Y Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.38
Quantity 32,000 -80.6%
Value US$492,278
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
15.26
Quantity 1,500 -13.9%
Value US$22,884
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
15.96
Quantity 1,500 -13.9%
Value US$23,938
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
16.97
Quantity 1,500 -13.9%
Value US$25,454
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
17.00
Quantity 5,000 -34.9%
Value US$85,000
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
15.45
Quantity 1,500 -13.9%
Value US$23,179
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
14.04
Quantity 1,500 -13.9%
Value US$21,062
WARD SCOTT R Non-Executive Director
Transaction date
Purchase
Price
15.69
Quantity 2,000 +inf%
Value US$31,380
ARMER THOMAS A Chief Scientific Officer Executive Director
Transaction date
Sale
Price
16.10
Quantity 30,000 -12.4%
Value US$482,979
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
15.86
Quantity 1,500 -13.9%
Value US$23,786
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
15.47
Quantity 2,500 -21.2%
Value US$38,677
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
16.79
Quantity 2,500 -28.1%
Value US$41,972
Friedman Charlene A VP President, Gen Counsel &Sec Officer
Transaction date
Planned sale
Price
15.50
Quantity 3,120 -100.0%
Value US$48,360
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
14.82
Quantity 2,500 -28.1%
Value US$37,052
HENWOOD GERALDINE Non-Executive Director
Transaction date
Planned sale
Price
15.66
Quantity 3,750 -100.0%
Value US$58,714
HENWOOD GERALDINE Non-Executive Director
Transaction date
Planned sale
Price
15.66
Quantity 4,387 -100.0%
Value US$68,714
HENWOOD GERALDINE Non-Executive Director
Transaction date
Planned sale
Price
15.65
Quantity 1,627 -100.0%
Value US$25,470
Friedman Charlene A VP President, Gen Counsel &Sec Officer
Transaction date
Planned sale
Price
15.53
Quantity 7,800 -100.0%
Value US$121,099
CHAI CHRISTOPHER Y Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.05
Quantity 16,000 -70.5%
Value US$224,808
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
11.21
Quantity 3,250 -33.7%
Value US$36,433
HENWOOD GERALDINE Non-Executive Director
Transaction date
Sale
Price
12.78
Quantity 12,000 -100.0%
Value US$153,407
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
13.49
Quantity 3,250 -33.7%
Value US$43,842
CHAI CHRISTOPHER Y Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.00
Quantity 8,000 -54.4%
Value US$104,000
CHAI CHRISTOPHER Y Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.42
Quantity 8,000 -54.4%
Value US$99,384
NELSON TIMOTHY S President and CEO Executive Director
Transaction date
Planned sale
Price
12.15
Quantity 15,000 -38.5%
Value US$182,289
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
12.47
Quantity 3,250 -33.7%
Value US$40,532
NELSON TIMOTHY S President and CEO Executive Director
Transaction date
Planned sale
Price
14.17
Quantity 3,480 -12.7%
Value US$49,294
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
14.39
Quantity 3,250 -33.7%
Value US$46,752
NELSON TIMOTHY S President and CEO Executive Director
Transaction date
Planned sale
Price
14.44
Quantity 26,520 -52.5%
Value US$383,031
CHAI CHRISTOPHER Y Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.77
Quantity 16,000 -70.5%
Value US$236,346
Friedman Charlene A VP President, Gen Counsel &Sec Officer
Transaction date
Planned sale
Price
17.07
Quantity 1,560 -100.0%
Value US$26,634
NELSON TIMOTHY S President and CEO Executive Director
Transaction date
Planned sale
Price
17.09
Quantity 30,000 -55.6%
Value US$512,790
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
18.30
Quantity 3,250 -33.7%
Value US$59,484
Friedman Charlene A VP President, Gen Counsel &Sec Officer
Transaction date
Planned sale
Price
18.03
Quantity 10,155 -100.0%
Value US$183,063
Friedman Charlene A VP President, Gen Counsel &Sec Officer
Transaction date
Planned sale
Price
16.05
Quantity 1,560 -100.0%
Value US$25,042
GIANAKAKOS ANASTASIOS SVP, Cor & Business Dev Officer
Transaction date
Planned sale
Price
15.92
Quantity 3,250 -33.7%
Value US$51,733
CHAI CHRISTOPHER Y Chief Financial Officer Officer
Transaction date
Planned sale
Price
16.47
Quantity 8,000 -54.4%
Value US$131,746
CHAI CHRISTOPHER Y Chief Financial Officer Officer
Transaction date
Planned sale
Price
16.72
Quantity 8,000 -54.4%
Value US$133,790
GOLDFISCHER CARL Non-Executive Director
Transaction date
Sale
Price
16.20
Quantity 115,610 -6.2%
Value US$1,872,882
GOLDFISCHER CARL Non-Executive Director
Transaction date
Sale
Price
16.01
Quantity 42,176 -2.2%
Value US$675,238
SOROS FUND MANAGEMENT LLC Large shareholder
Transaction date
Sale
Price
16.11
Quantity 706 -0.0%
Value US$11,374
GOLDFISCHER CARL Non-Executive Director
Transaction date
Sale
Price
16.30
Quantity 105,000 -5.2%
Value US$1,711,500
GOLDFISCHER CARL Non-Executive Director
Transaction date
Sale
Price
16.06
Quantity 54,300 -2.6%
Value US$872,058
Bay City Capital Fund IV, L.P. Large shareholder
Transaction date
Sale
Price
16.06
Quantity 54,300 -2.6%
Value US$872,058
ELMS STEVE Non-Executive Director
Transaction date
Sale
Price
16.15
Quantity 2,090 -100.0%
Value US$33,754
GOLDFISCHER CARL Non-Executive Director
Transaction date
Sale
Price
16.03
Quantity 134,190 -6.1%
Value US$2,151,066
Bay City Capital Fund IV, L.P. Large shareholder
Transaction date
Sale
Price
16.03
Quantity 134,190 -6.1%
Value US$2,151,066
PERSEUSPUR LLC Large shareholder
Transaction date
Sale
Price
16.04
Quantity 3,925 -0.1%
Value US$62,957
GOLDFISCHER CARL Non-Executive Director
Transaction date
Sale
Price
15.50
Quantity 151,424 -6.5%
Value US$2,347,072
Bay City Capital Fund IV, L.P. Large shareholder
Transaction date
Sale
Price
15.50
Quantity 151,424 -6.5%
Value US$2,347,072
PERSEUSPUR LLC Large shareholder
Transaction date
Sale
Price
15.21
Quantity 5,000 -0.2%
Value US$76,050
SOROS FUND MANAGEMENT LLC Large shareholder
Transaction date
Sale
Price
15.40
Quantity 16,366 -0.6%
Value US$252,036
SOROS FUND MANAGEMENT LLC Large shareholder
Transaction date
Sale
Price
15.40
Quantity 634 -0.0%
Value US$9,764
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-03-04 2013-02-28 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
27,975 -28.1%
59.22
US$4,587,950 		27,975 -28.1% 59.22 US$4,587,950
2013-03-04 2013-02-28 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
2,081 -9.4%
424.76
US$1,785,509 		2,081 -9.4% 424.76 US$1,785,509
2013-01-29 2013-01-26 S Sale Borland Scott

SVP, Neurology Franchise

Officer
4,131 -47.6%
297.46
US$3,585,821 		4,131 -47.6% 297.46 US$3,585,821
2013-01-25 2013-01-23 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
80,000 -70.8%
24.76
US$1,980,800 		80,000 -70.8% 24.76 US$1,980,800
2013-01-25 2013-01-23 PlS Planned sale ARMER THOMAS A

Chief Scientific Officer

Executive Director
59,620 -31.6%
24.76
US$1,476,191 		59,620 -31.6% 24.76 US$1,476,191
2013-01-25 2013-01-23 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
30,000 -67.7%
24.76
US$742,800 		30,000 -67.7% 24.76 US$742,800
2012-11-27 2012-11-23 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
3,750 -100.0%
15.00
US$56,250 		3,750 -100.0% 15.00 US$56,250
2012-11-27 2012-11-23 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
1,490 -100.0%
15.00
US$22,350 		1,490 -100.0% 15.00 US$22,350
2012-11-05 2012-11-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
5,767 -31.8%
15.64
US$90,203 		5,767 -31.8% 15.64 US$90,203
2012-04-04 2012-04-02 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
2,500 -16.8%
14.38
US$35,946 		2,500 -16.8% 14.38 US$35,946
2012-03-13 2012-03-09 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
10,000 -44.7%
17.50
US$175,000 		10,000 -44.7% 17.50 US$175,000
2012-03-13 2012-03-09 PlS Planned sale Friedman Charlene A

SVP, Gen Counsel & Sec

Officer
10,000 -88.4%
17.50
US$175,000 		10,000 -88.4% 17.50 US$175,000
2012-02-22 2012-02-21 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Business Officer

Officer
1,385 -10.1%
15.99
US$22,153 		1,385 -10.1% 15.99 US$22,153
2012-02-22 2012-02-21 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Business Officer

Officer
1,115 -8.3%
16.02
US$17,864 		1,115 -8.3% 16.02 US$17,864
2012-02-14 2012-02-14 PlS Planned sale ARMER THOMAS A

Chief Scientific Officer

Executive Director
30,999 -17.2%
15.62
US$484,142 		30,999 -17.2% 15.62 US$484,142
2012-02-07 2012-02-06 PlS Planned sale ARMER THOMAS A

Chief Scientific Officer

Executive Director
19,868 -8.7%
15.00
US$298,020 		19,868 -8.7% 15.00 US$298,020
2012-02-07 2012-02-06 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Business Officer

Officer
10,000 -44.7%
15.00
US$150,000 		10,000 -44.7% 15.00 US$150,000
2012-01-20 2012-01-19 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Business Officer

Officer
4,471 -32.4%
13.88
US$62,078 		4,471 -32.4% 13.88 US$62,078
2011-12-22 2011-12-21 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
6,638 -17.5%
14.52
US$96,414 		6,638 -17.5% 14.52 US$96,414
2011-12-22 2011-12-20 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
13,362 -29.9%
14.50
US$193,809 		13,362 -29.9% 14.50 US$193,809
2011-12-14 2011-12-12 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Bus Officer

Officer
13 -0.1%
8,672.00
US$113,190 		13 -0.1% 8,672.00 US$113,190
2011-12-14 2011-12-12 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Bus Officer

Officer
1,328 -12.5%
13.28
US$17,630 		1,328 -12.5% 13.28 US$17,630
2011-09-22 2011-09-20 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
32,000 -80.6%
15.38
US$492,278 		32,000 -80.6% 15.38 US$492,278
2011-08-03 2011-08-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
15.26
US$22,884 		1,500 -13.9% 15.26 US$22,884
2011-07-05 2011-07-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
15.96
US$23,938 		1,500 -13.9% 15.96 US$23,938
2011-06-03 2011-06-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
16.97
US$25,454 		1,500 -13.9% 16.97 US$25,454
2011-05-10 2011-05-09 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
5,000 -34.9%
17.00
US$85,000 		5,000 -34.9% 17.00 US$85,000
2011-05-03 2011-05-02 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
15.45
US$23,179 		1,500 -13.9% 15.45 US$23,179
2011-04-04 2011-04-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
14.04
US$21,062 		1,500 -13.9% 14.04 US$21,062
2011-03-15 2011-03-11 B Purchase WARD SCOTT R Non-Executive Director
2,000 +inf%
15.69
US$31,380 		2,000 +inf% 15.69 US$31,380
2011-03-08 2011-03-04 S Sale ARMER THOMAS A

Chief Scientific Officer

Executive Director
30,000 -12.4%
16.10
US$482,979 		30,000 -12.4% 16.10 US$482,979
2011-03-02 2011-03-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
15.86
US$23,786 		1,500 -13.9% 15.86 US$23,786
2011-02-03 2011-02-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
2,500 -21.2%
15.47
US$38,677 		2,500 -21.2% 15.47 US$38,677
2011-01-04 2011-01-03 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
2,500 -28.1%
16.79
US$41,972 		2,500 -28.1% 16.79 US$41,972
2010-12-21 2010-12-20 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
3,120 -100.0%
15.50
US$48,360 		3,120 -100.0% 15.50 US$48,360
2010-12-17 2010-12-15 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
2,500 -28.1%
14.82
US$37,052 		2,500 -28.1% 14.82 US$37,052
2010-10-29 2010-10-27 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
3,750 -100.0%
15.66
US$58,714 		3,750 -100.0% 15.66 US$58,714
2010-10-29 2010-10-27 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
4,387 -100.0%
15.66
US$68,714 		4,387 -100.0% 15.66 US$68,714
2010-10-29 2010-10-27 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
1,627 -100.0%
15.65
US$25,470 		1,627 -100.0% 15.65 US$25,470
2010-10-29 2010-10-27 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
7,800 -100.0%
15.53
US$121,099 		7,800 -100.0% 15.53 US$121,099
2010-09-22 2010-09-20 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
16,000 -70.5%
14.05
US$224,808 		16,000 -70.5% 14.05 US$224,808
2010-09-03 2010-09-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
11.21
US$36,433 		3,250 -33.7% 11.21 US$36,433
2010-08-06 2010-08-05 S Sale HENWOOD GERALDINE Non-Executive Director
12,000 -100.0%
12.78
US$153,407 		12,000 -100.0% 12.78 US$153,407
2010-08-02 2010-08-02 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
13.49
US$43,842 		3,250 -33.7% 13.49 US$43,842
2010-07-22 2010-07-21 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
8,000 -54.4%
13.00
US$104,000 		8,000 -54.4% 13.00 US$104,000
2010-07-22 2010-07-20 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
8,000 -54.4%
12.42
US$99,384 		8,000 -54.4% 12.42 US$99,384
2010-07-02 2010-07-01 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
15,000 -38.5%
12.15
US$182,289 		15,000 -38.5% 12.15 US$182,289
2010-07-02 2010-07-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
12.47
US$40,532 		3,250 -33.7% 12.47 US$40,532
2010-06-03 2010-06-03 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
3,480 -12.7%
14.17
US$49,294 		3,480 -12.7% 14.17 US$49,294
2010-06-03 2010-06-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
14.39
US$46,752 		3,250 -33.7% 14.39 US$46,752
2010-06-03 2010-06-01 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
26,520 -52.5%
14.44
US$383,031 		26,520 -52.5% 14.44 US$383,031
2010-05-21 2010-05-20 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
16,000 -70.5%
14.77
US$236,346 		16,000 -70.5% 14.77 US$236,346
2010-05-14 2010-05-13 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
1,560 -100.0%
17.07
US$26,634 		1,560 -100.0% 17.07 US$26,634
2010-05-14 2010-05-13 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
30,000 -55.6%
17.09
US$512,790 		30,000 -55.6% 17.09 US$512,790
2010-05-05 2010-05-03 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
18.30
US$59,484 		3,250 -33.7% 18.30 US$59,484
2010-04-28 2010-04-26 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
10,155 -100.0%
18.03
US$183,063 		10,155 -100.0% 18.03 US$183,063
2010-04-15 2010-04-14 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
1,560 -100.0%
16.05
US$25,042 		1,560 -100.0% 16.05 US$25,042
2010-04-05 2010-04-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
15.92
US$51,733 		3,250 -33.7% 15.92 US$51,733
2010-03-25 2010-03-24 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
8,000 -54.4%
16.47
US$131,746 		8,000 -54.4% 16.47 US$131,746
2010-03-25 2010-03-23 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
8,000 -54.4%
16.72
US$133,790 		8,000 -54.4% 16.72 US$133,790
2010-03-16 2010-03-16 S Sale GOLDFISCHER CARL Non-Executive Director
115,610 -6.2%
16.20
US$1,872,882 		115,610 -6.2% 16.20 US$1,872,882
2010-03-16 2010-03-15 S Sale GOLDFISCHER CARL Non-Executive Director
42,176 -2.2%
16.01
US$675,238 		42,176 -2.2% 16.01 US$675,238
2010-03-16 2010-03-12 S Sale SOROS FUND MANAGEMENT LLC Large shareholder
706 -0.0%
16.11
US$11,374 		706 -0.0% 16.11 US$11,374
2010-03-16 2010-03-12 S Sale GOLDFISCHER CARL Non-Executive Director
105,000 -5.2%
16.30
US$1,711,500 		105,000 -5.2% 16.30 US$1,711,500
2010-03-11 2010-03-11 S Sale GOLDFISCHER CARL Non-Executive Director
54,300 -2.6%
16.06
US$872,058 		54,300 -2.6% 16.06 US$872,058
2010-03-11 2010-03-11 S Sale Bay City Capital Fund IV, L.P. Large shareholder
54,300 -2.6%
16.06
US$872,058 		54,300 -2.6% 16.06 US$872,058
2010-03-12 2010-03-10 S Sale ELMS STEVE Non-Executive Director
2,090 -100.0%
16.15
US$33,754 		2,090 -100.0% 16.15 US$33,754
2010-03-11 2010-03-10 S Sale GOLDFISCHER CARL Non-Executive Director
134,190 -6.1%
16.03
US$2,151,066 		134,190 -6.1% 16.03 US$2,151,066
2010-03-11 2010-03-10 S Sale Bay City Capital Fund IV, L.P. Large shareholder
134,190 -6.1%
16.03
US$2,151,066 		134,190 -6.1% 16.03 US$2,151,066
2010-03-10 2010-03-10 S Sale PERSEUSPUR LLC Large shareholder
3,925 -0.1%
16.04
US$62,957 		3,925 -0.1% 16.04 US$62,957
2010-03-11 2010-03-09 S Sale GOLDFISCHER CARL Non-Executive Director
151,424 -6.5%
15.50
US$2,347,072 		151,424 -6.5% 15.50 US$2,347,072
2010-03-11 2010-03-09 S Sale Bay City Capital Fund IV, L.P. Large shareholder
151,424 -6.5%
15.50
US$2,347,072 		151,424 -6.5% 15.50 US$2,347,072
2010-03-10 2010-03-09 S Sale PERSEUSPUR LLC Large shareholder
5,000 -0.2%
15.21
US$76,050 		5,000 -0.2% 15.21 US$76,050
2010-03-10 2010-03-09 S Sale SOROS FUND MANAGEMENT LLC Large shareholder
16,366 -0.6%
15.40
US$252,036 		16,366 -0.6% 15.40 US$252,036
2010-03-10 2010-03-09 S Sale SOROS FUND MANAGEMENT LLC Large shareholder
634 -0.0%
15.40
US$9,764 		634 -0.0% 15.40 US$9,764
Explore more

More insider trading research around MAP Pharmaceuticals, Inc.

More insider trades in United States
Insider trading in North America